HQL-79
Product Specifications
CAS Number
162641-16-9
Target
Others, PGE Synthase
Related Pathways
Others, Immunology/Inflammation
Bioactivity
HQL-79 is a selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor. It inhibits the synthesis of PGD2 and acts as an anti-allergic agent (Kd: 0.8 μM and IC50: 6 μM) . It also shows no obvious effect on COX-1, COX-2, m-PGES, or L-PGDS.
Smiles
C(CN1CCC(CC1)OC(c1ccccc1)c1ccccc1)Cc1nnn[nH]1
Molecular Formula
C22H27N5O
Molecular Weight
377.48
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6217609-01 0.1 mL
IL8 (Interleukin 8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1) (MaxLight 550)
Sign In for Pricing
View Details MBS6217609-02 5x 0.1 mL
IL8 (Interleukin 8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1) (MaxLight 550)
Sign In for Pricing
View Details D1500-25L 250 µg
DcR3 (TR6, Decoy Receptor 3, TNFRSF6B, TR6, M68) (Biotin)
Sign In for Pricing
View Details 